JAK2 and acquired polycythemia vera: JAK2 V617F associated abnormalities are more common in patients with polycythemia vera or primary myelofibrosis where allele burden is much higher than in ET.23,24 Correlations between JAK2 V617F allele burden and clinical features in ET are not as definite.